Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
29%
Ph phase_1
3
43%
Ph phase_3
2
29%

Phase Distribution

3

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (42.9%)
Phase 22 (28.6%)
Phase 32 (28.6%)

Trials by Status

completed686%
not_yet_recruiting114%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingphase_2

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

NCT07303803
completedphase_2

Chiglitazar/Metformin in Non-obese Women With PCOS

NCT06125587
completedphase_1

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

NCT05515458
completedphase_1

Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function

NCT05515445
completedphase_1

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

NCT05681273
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07303803Phase 2

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Not Yet Recruiting
NCT06125587Phase 2

Chiglitazar/Metformin in Non-obese Women With PCOS

Completed
NCT05515458Phase 1

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

Completed
NCT05515445Phase 1

Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function

Completed
NCT05681273Phase 1

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

Completed
NCT02121717Phase 3

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

Completed
NCT02173457Phase 3

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7